Timothy Poirier
Optometrist · Knightdale, NCNPI 1053420638
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Dompe US, Inc. accounts for 75.3% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $29,712 and has fallen 51.4% since, to $14,432 in 2025. Among optometrist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $283.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dompe US, Inc.$98K
- Johnson & Johnson Surgical Vision, Inc.$24K
- Bausch & Lomb Americas Inc.$3K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$890
- Johnson & Johnson Vision Care, Inc.$625
- AbbVie$535
- plus $3K from 21 others
Across 26 payments — averaging $34.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$900
What the payments were for
- Consulting fees$22,15017%
- Speaking & faculty fees$70,10354%
- Travel & lodging$25,09819%
- Food & beverage$12,35010%
- Entertainment$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dompe US, Inc. | 221 | $97,704 |
| Johnson & Johnson Surgical Vision, Inc. | 34 | $24,244 |
| Bausch & Lomb Americas Inc. | 69 | $3,108 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 29 | $890 |
| Johnson & Johnson Vision Care, Inc. | 16 | $625 |
| AbbVie(2 entities) | 14 | $535 |
| Mallinckrodt Hospital Products Inc. | 11 | $398 |
| Alcon | 6 | $361 |
| Kala Pharmaceuticals, Inc. | 6 | $233 |
| Notal Vision, Inc. | 11 | $208 |
| Biotissue Holdings Inc. | 5 | $197 |
| Tarsus Pharmaceuticals, Inc. | 5 | $187 |
| Sun Pharmaceutical Industries Inc. | 5 | $151 |
| Shire North American Group Inc | 2 | $143 |
| Rxsight Inc | 1 | $137 |
| ANI Pharmaceuticals, Inc. | 4 | $109 |
| Amgen | 2 | $106 |
| Harrow Eye, LLC | 3 | $97 |
| Visioneering Technologies, Inc. | 4 | $65 |
| ABB Con-cise Optical Group LLC | 1 | $61 |
| Aerie Pharmaceuticals, Inc. | 3 | $43 |
| Alimera Sciences, Inc. | 1 | $25 |
| Novartis | 1 | $23 |
| Thea Pharma Inc. | 1 | $21 |
| Optos, Inc. | 1 | $21 |
| Sight Sciences, Inc. | 1 | $19 |
| Coopervision Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxervate$93,737
- TearScience Lipiflow System$8,119
- TearScience Lipiview System$8,119
- TearScience Lipiscan System$8,119
- Tecnis IOL$2,684
- INFUSE$1,772
- Tecnis Simplicity$895
- ACTHAR$242
- Hydrus Microstent$229
- Acuvue$225
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$137
- VYZULTA$130
- ULTRA MULTIFOCAL TORIC$125
- EYSUVIS$122
- BIOTRUE ONE DAY$120
- XDEMVY$120
- XIIDRA$115
- VUITY$102
- LUMIGAN$100
How this compares
$129,721 in reported general payments places this provider in the 95th percentile of 1,326 optometrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 36 | $1,997,545 |
| LumiganBimatoprost | 81 | $36,494 |
| RestasisCyclosporine | 24 | $25,814 |
| CombiganBrimonidine Tartrate/Timolol | 28 | $15,230 |
| VyzultaLatanoprostene Bunod | 36 | $14,280 |
| CequaCyclosporine | 11 | $6,652 |
| Alphagan PBrimonidine Tartrate | 12 | $3,837 |
| Lotemax SmLoteprednol Etabonate | 15 | $3,737 |
| Latanoprost | 147 | $1,707 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 11 | $1,090 |
| Prednisolone Acetate | 28 | $1,006 |
| Timolol Maleate | 35 | $335 |
| Dorzolamide Hcl | 11 | $289 |
| Brimonidine Tartrate | 16 | $178 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $97,704 | $1,997,54536 claims |
| AbbVieLumigan, Restasis, Combigan, Alphagan P | $535 | $81,374145 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $3,108 | $14,28036 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $151 | $6,65211 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm | $890 | $3,73715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,326 optometrist providers in North Carolina.
Other optometrist in Knightdale
- Crystal BrimerWilmington$920K
- Osama SaidRaleigh$597K
- Ryan CorteAsheville$569K
- Sanjay PatelApex$518K
- Sean SmolenyakRaleigh$512K
- Rachael WrubleBelmont$228K
- Lisa GreeneArden$186K
- Jennifer LyerlyMorrisville$164K
- Randall ThomasConcord$126K
- David WichnoskiCharlotte$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.